Skip to main content
OpenTrials
Completed

NCT Number: NCT03624855

Implant-Associated P. Aeruginosa Bone And Joint Infections : Experience In A Regional Reference Center In France

The aim of this study is to describe the bone or joint infection due to Pseudomonas aeruginosa in patients having implant.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bone and Joint Infection

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospices Civils de Lyon

Lyon, 69004, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients having BJI on implant caused by Pseudomonas aeruginosa

Exclusion criteria

-

Treatment and study plan

Bone or joint infection due to Pseudomonas aeruginosa

Other

Description of bone or joint infection on implant due to Pseudomonas aeruginosa

Primary outcomes

  1. Description and rate of bone or joint infection on implant caused due to Pseudomonas aeruginosa

    Time frame: Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)

    Description of the type of infection due to P. aeruginosa : patients and type of implant, profile of the bacterium, medical and chirurgical treatment, rate

Secondary outcomes

  1. Rate of adverse events occurring under medical treatment against Pseudomonas aeruginosa

    Time frame: Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)

    description of adverse events occurring under medical treatment against Pseudomonas aeruginosa in BJI

  2. Rate of Treatment Failure

    Time frame: Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)

    Treatment failure is defined by local clinical and/or microbiological relapse; and/or need for additional surgery; death of septic origin

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Aug 10, 2018
Registry last updated
Aug 13, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.